Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGICAL DMARDS: RESULTS AT 60 WEEKS FROM THE SELECT-BEYOND STUDY Genovese, M. C., Combe, B., Hall, S., Rubbert-Roth, A., Zhong, S., Meerwein, S., Pangan, A., Fleischmann, R. BMJ PUBLISHING GROUP. 2019: 360–61
View details for DOI 10.1136/annrheumdis-2019-eular.2285
View details for Web of Science ID 000472207101081